A person’s microbiome, or the collection of all microorganisms that live in the gut, can enhance the body’s antitumor response…
Articles by Marisa Wexler, MS
Most people with relapsed or refractory multiple myeloma (RRMM) given the cell therapy anitocabtagene autoleucel — known as anito-cel…
The cell therapy Carvykti (ciltacabtagene autoleucel) — approved earlier this year as a second-line treatment for people with multiple myeloma…
Vitamin D may help to prevent the development of ovarian cancers, according to new studies in mice and cell…
U.S. scientists have discovered that pediatric low-grade gliomas — a type of brain cancer that can occur in children —…
A combination therapy using Blenrep (belantamab mafodotin) was more effective at extending life in people with relapsed or refractory multiple…
The U.S. Food and Drug Administration (FDA) has approved the cell therapy Aucatzyl (obecabtagene autoleucel) to treat adults with relapsed…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to MB-108, an experimental virus-based therapy that…
Johnson & Johnson (J&J) is asking regulatory authorities in the European Union to approve a combination treatment based on…
A single infusion of the CAR T-cell therapy Carvykti (ciltacabtagene autoleucel) was sufficient to control disease activity in most…